期刊文献+

纳米颗粒疫苗研究进展 被引量:5

Advances in the Research of Nanoparticle Vaccines
下载PDF
导出
摘要 纳米颗粒指小于100-1000nm的微粒,纳米颗粒疫苗不但能提高抗原的稳定性和免疫原性,而且能够靶向性递呈抗原和缓慢释放,增强机体产生免疫应答。综述了近年来纳米颗粒在疫苗发展过程中的应用,介绍了不同纳米颗粒作为运输系统或免疫佐剂与免疫细胞之间的相互作用。 Nanoparticles are defined as any particulate materials with size 100--1 000 nanometres. The use of nanoparticles in vaccine formulations not only improves antigen stability and immuno- genicity, but also allows targeted delivery and slow release,inducing the production of immune re- sponses. In this review,we provide an overview of recent advances in the broad area of nanovacci- nology. Types of nanoparticles used are outlined and their interaction with immune cells and the biosystem are discussed.
出处 《河南农业科学》 CSCD 北大核心 2014年第4期21-25,共5页 Journal of Henan Agricultural Sciences
基金 中国博士后科学基金项目(2011M501179) 河南省教育厅科学技术研究重点项目(13A230838)
关键词 疫苗 纳米颗粒 佐剂 纳米技术 vaccine nanoparticle adjuvant nanotechnology
  • 相关文献

参考文献31

  • 1Mamo T,Poland G A. Nanovaccinology: The next gen- eration of vaccines meets 21st century materials science and engineering[J]. Vaccine, 2012,30 ( 47 ) : 6609-6611.
  • 2Smith D M, Simon J K, Baker J R Jr. Applications of nanotechnology for immunology[J]. Nat Rev Immu- nol, 2013,13 (8) : 592-605.
  • 3胡骁飞,李艳梅,王方雨,邢广旭,孙亚宁,仝其宾.免疫学技术在霉菌毒素检测中的应用[J].河南农业科学,2013,42(4):157-160. 被引量:4
  • 4Treuel L,Jiang X,Nienhaus G U. New views on cellu- lar uptake and trafficking of manufactured nanoparti- eles[J]. J R Soc Interface, 2013,10 (82): 20120939.
  • 5张红英,王学兵,崔保安,赵现敏,陈红英,金钺.山药多糖对PRRSV灭活苗免疫猪抗体和T细胞亚群的影响[J].华北农学报,2010,25(2):236-238. 被引量:33
  • 6张雪寒,何孔旺,卢维彩,赵攀登,温立斌,李彬,郭容利,王小敏,倪艳秀,周俊明,俞正玉,茅爱华,吕立新.出血性大肠杆菌O157:H7 Stx2B-Tir-Stx1B多价融合蛋白表达及免疫原性研究[J].华北农学报,2010,25(4):180-185. 被引量:9
  • 7Bolhassani A,Safaiyan S, Rafati S. Improvement of dif- ferent vaccine deliverysystems for cancer therapy[J]. Mol Cancer, 2011,10 : 3-22.
  • 8Liu F,Ge S, Li L,et al. Virus-like particles:Potential veterinary vaccine immunogens[J]. Res Vet Sci, 2012, 2:553-559.
  • 9Crisci E,Bcircena J, Montoya M. Virus-like particles: The new frontier of vaccines for animal viral infec- tions. [J]. Vet Immunol Immunopathol, 2012,148 (3/ 4):211-225.
  • 10Kushnir N,Streatfield S J,Yusibov V. Virus-like par- ticles as a highly efficient vaccine platforrn: Diversity of targets and production systems andadvances in clinical development[J]. Vaccine, 2012,31 ( 1 ) : 58-83.

二级参考文献82

共引文献71

同被引文献60

  • 1曹灵芝,王钊铄,王蓓.纳米生物材料在抗病毒疫苗佐剂中的应用[J].应用化学,2021,38(5):572-581. 被引量:3
  • 2寇亚楠,刘石,王瑞宁,耿静微,徐卫松,陈红英,崔保安,杨国宇,魏战勇.纳米铝胶佐剂增强猪细小病毒灭活疫苗猪体免疫的效果[J].中国兽医学报,2015,35(1):25-30. 被引量:6
  • 3周红莉,郭丽,王健伟,洪涛.粘膜免疫佐剂研究进展[J].中国生物工程杂志,2006,26(3):83-88. 被引量:13
  • 4赫捷,陈万青.2012中国肿瘤登记年报[M].北京:军事医学科学出版社,2012:12-25.
  • 5Banchereau J,Steinman RM.Dendritic cells and the control of immunity[J].Nature,1998,392(6673):245-252.
  • 6Brossart P,Heinrich KS,Stuhler G,et al.Identification of HLA-A2-restricted T-cell epitopes derived from the MUCl tumor antigen for broadly applicable vaccine therapies[J].Blood,1999,93(12):4309-4317.
  • 7Brossart P,Schneider A,Dill P,et al.The epithelial tumor antigen MUCl is expressed in hematological malignancies and is recognized by MUCl-specific cytotoxic T- Iymphocytes[J].Cancer Res,2001,61(18):6846-6850.
  • 8Brossart P,Wirths S,Stuhler G,et al.Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells[J].Blood,2000,96(9):3102-3108.
  • 9Ma Y,Zhuang Y,Xie X,et al.The role of surface charge density in cationic liposome-promoted dendritic cell maturation and vaccine-induced immune responses[J].Nanoscale,2011,3(5):2307-2314.
  • 10Wang C,Liu P,Zhuang Y,et al.Lymphatic-targeted cationic liposomes:a robust vaccine adjuvant for promoting long-term immunological memory[J].Vaccine,2014,32(42):5475-5483.

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部